The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chernoff, A. E.
Right arrow Articles by Dinarello, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernoff, A. E.
Right arrow Articles by Dinarello, C. A.

The Journal of Immunology, Vol 154, Issue 10 5492-5499, Copyright © 1995 by American Association of Immunologists

ARTICLES

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses

AE Chernoff, EV Granowitz, L Shapiro, E Vannier, G Lonnemann, JB Angel, JS Kennedy, AR Rabson, SM Wolff and CA Dinarello
Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.

In vitro, IL-10 inhibits T cell proliferation and LPS-induced monocyte production of IL-1, TNF-alpha, IL-6, and IL-8. We studied the safety and immunomodulatory effects of IL-10 administration in humans. Seventeen healthy volunteers received a single i.v. bolus injection of either human IL-10 (1, 10, or 25 micrograms/kg) or placebo. Routine safety parameters, lymphocyte phenotypes, T cell proliferative responses, and stimulus-induced cytokine production were assessed before and 3, 6, 24, and 48 h after injection. There were no adverse symptoms or signs after IL-10 administration. A transient neutrophilia and monocytosis that peaked at 6 h (45-160% above base line) was observed. However, lymphocyte counts fell by 25% 3 and 6 h after the injection (p < 0.01). In particular, lymphocytes expressing the T cell surface markers CD2, CD3, CD4, CD7, and CD8 were significantly decreased. Mitogen-induced T cell proliferation was suppressed by up to 50% (p < 0.01) in the two higher dose groups. Significant dose- dependent inhibition (65-95%) of TNF-alpha and IL-1 beta production from whole blood stimulated ex vivo with endotoxin occurred after each dose of IL-10. In contrast, there was no reduction in the production of their respective antagonists, TNF soluble receptor p55 or IL-1 receptor antagonist. We conclude that a single intravenous injection of IL-10 is safe in humans, has inhibitory effects on T cells, and suppresses production of the pro-inflammatory cytokines TNF-alpha and IL-1 beta.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
G. B. Pott, E. D. Chan, C. A. Dinarello, and L. Shapiro
{alpha}-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
J. Leukoc. Biol., May 1, 2009; 85(5): 886 - 895.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
W.-D. Docke, K. Asadullah, G. Belbe, M. Ebeling, C. Hoflich, M. Friedrich, W. Sterry, and H.-D. Volk
Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis
J. Leukoc. Biol., March 1, 2009; 85(3): 582 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J.-E. Ghia, P. Blennerhassett, and S. M. Collins
Vagus nerve integrity and experimental colitis
Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G560 - G567.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
Y. Houri-Haddad, W.A. Soskolne, A. Halabi, and L. Shapira
IL-10 Gene Transfer Attenuates P. gingivalis-induced Inflammation
Journal of Dental Research, June 1, 2007; 86(6): 560 - 564.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Liu, X. Gao, E. Masuda, P. B. Redecha, M. C. Blank, and L. Pricop
Regulated Expression of Fc{gamma}R in Human Dendritic Cells Controls Cross-Presentation of Antigen-Antibody Complexes
J. Immunol., December 15, 2006; 177(12): 8440 - 8447.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. C. Ng, K. Li, T. F. Leung, R. P.O. Wong, G. Li, K. M. Chui, E. Wong, F. W.T. Cheng, and T. F. Fok
Early Prediction of Sepsis-Induced Disseminated Intravascular Coagulation with Interleukin-10, Interleukin-6, and RANTES in Preterm Infants
Clin. Chem., June 1, 2006; 52(6): 1181 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Miyamoto, T. Kaneko, M. Yamashita, Y. Tenda, M. Inami, A. Suzuki, S. Ishii, M. Kimura, K. Hashimoto, H. Shimada, et al.
Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administration
Int. Immunol., June 1, 2005; 17(6): 759 - 768.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nakagome, M. Dohi, K. Okunishi, Y. Komagata, K. Nagatani, R. Tanaka, J.-i. Miyazaki, and K. Yamamoto
In Vivo IL-10 Gene Delivery Suppresses Airway Eosinophilia and Hyperreactivity by Down-Regulating APC Functions and Migration without Impairing the Antigen-Specific Systemic Immune Response in a Mouse Model of Allergic Airway Inflammation
J. Immunol., June 1, 2005; 174(11): 6955 - 6966.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Liu, E. Masuda, M. C. Blank, K. A. Kirou, X. Gao, M.-S. Park, and L. Pricop
Cytokine-mediated regulation of activating and inhibitory Fc{gamma} receptors in human monocytes
J. Leukoc. Biol., May 1, 2005; 77(5): 767 - 776.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
L. Rodriguez, C. Gonzalez, L. Flores, L. Jimenez-Zamudio, J. Graniel, and R. Ortiz
Assessment by Flow Cytometry of Cytokine Production in Malnourished Children
Clin. Vaccine Immunol., April 1, 2005; 12(4): 502 - 507.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
H Schotte, B Schluter, S Drynda, P Willeke, N Tidow, G Assmann, W Domschke, J Kekow, and M Gaubitz
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
Ann Rheum Dis, April 1, 2005; 64(4): 575 - 581.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Chi, E. Messas, R. A. Levine, D. T. Graves, and S. Amar
Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications
Circulation, September 21, 2004; 110(12): 1678 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
H. Schotte, B. Schluter, P. Willeke, E. Mickholz, M. A. Schorat, W. Domschke, and M. Gaubitz
Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis
Rheumatology, August 1, 2004; 43(8): 960 - 964.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
E. Liang, Y. N. Wong, I. Allen, R. Kao, M. Marino, and C. DiLea
Pharmacokinetics of E5564, a Lipopolysaccharide Antagonist, in Patients with Impaired Hepatic Function
J. Clin. Pharmacol., December 1, 2003; 43(12): 1361 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. E. Smith, V. Patel, S. D. Seatter, M. R. Deehan, M. H. Brown, G. P. Brooke, H. S. Goodridge, C. J. Howard, K. P. Rigley, W. Harnett, et al.
A novel MyD-1 (SIRP-1{alpha}) signaling pathway that inhibits LPS-induced TNF{alpha} production by monocytes
Blood, October 1, 2003; 102(7): 2532 - 2540.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. S. Farivar, B. Krishnadasan, B. V. Naidu, S. M. Woolley, E. D. Verrier, and M. S. Mulligan
Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury
Ann. Thorac. Surg., July 1, 2003; 76(1): 253 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
J. Jiang, E. Yamato, and J.-i. Miyazaki
Sustained Expression of Fc-Fusion Cytokine Following In Vivo Electroporation and Mouse Strain Differences in Expression Levels
J. Biochem., April 1, 2003; 133(4): 423 - 427.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A.-F. Petit-Bertron, C. Fitting, J.-M. Cavaillon, and M. Adib-Conquy
Adherence influences monocyte responsiveness to interleukin-10
J. Leukoc. Biol., January 1, 2003; 73(1): 145 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. Ikeda, K. Sato, N. Kuwada, T. Matsumura, T. Yamashita, F. Kimura, K. Hatake, K. Ikeda, and K. Motoyoshi
Interleukin-10 differently regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3
J. Leukoc. Biol., December 1, 2002; 72(6): 1198 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
D S Hallegua and M H Weisman
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases
Ann Rheum Dis, November 1, 2002; 61(11): 960 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
A. B. Kimball, T. Kawamura, K. Tejura, C. Boss, A. R. Hancox, J. C. Vogel, S. M. Steinberg, M. L. Turner, and A. Blauvelt
Clinical and Immunologic Assessment of Patients With Psoriasis in a Randomized, Double-blind, Placebo-Controlled Trial Using Recombinant Human Interleukin 10
Arch Dermatol, October 1, 2002; 138(10): 1341 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. B. McInnes, G. G. Illei, C. L. Danning, C. H. Yarboro, M. Crane, T. Kuroiwa, R. Schlimgen, E. Lee, B. Foster, D. Flemming, et al.
IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis
J. Immunol., October 1, 2001; 167(7): 4075 - 4082.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. E. Greilich, K. Okada, P. Latham, R. R. Kumar, and M. E. Jessen
Aprotinin But Not {epsilon}-Aminocaproic Acid Decreases Interleukin-10 After Cardiac Surgery With Extracorporeal Circulation: Randomized, Double-Blind, Placebo-Controlled Study in Patients Receiving Aprotinin and {epsilon}-Aminocaproic Acid
Circulation, September 18, 2001; 104 (2009): I-265 - I-269.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
E. Crawley, S. Kon, and P. Woo
Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis
Rheumatology, May 1, 2001; 40(5): 574 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. Diterich, L. Harter, D. Hassler, A. Wendel, and T. Hartung
Modulation of Cytokine Release in Ex Vivo-Stimulated Blood from Borreliosis Patients
Infect. Immun., February 1, 2001; 69(2): 687 - 694.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. van Deventer, and T. van der Poll
Proinflammatory Effects of IL-10 During Human Endotoxemia
J. Immunol., September 1, 2000; 165(5): 2783 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
G Barbara, Z Xing, C M Hogaboam, J Gauldie, and S M Collins
Interleukin 10 gene transfer prevents experimental colitis in rats
Gut, March 1, 2000; 46(3): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. J. Feldman, L. Aguirre, M. Ziol, J.-P. Bridou, N. Nevo, J.-B. Michel, and P. G. Steg
Interleukin-10 Inhibits Intimal Hyperplasia After Angioplasty or Stent Implantation in Hypercholesterolemic Rabbits
Circulation, February 29, 2000; 101(8): 908 - 916.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. J. Quinn, S. Taylor, C. L. Wohlford-Lenane, and D. A. Schwartz
IL-10 reduces grain dust-induced airway inflammation and airway hyperreactivity
J Appl Physiol, January 1, 2000; 88(1): 173 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. E. Loercher, M. A. Nash, J. J. Kavanagh, C. D. Platsoucas, and R. S. Freedman
Identification of an IL-10-Producing HLA-DR-Negative Monocyte Subset in the Malignant Ascites of Patients with Ovarian Carcinoma That Inhibits Cytokine Protein Expression and Proliferation of Autologous T Cells
J. Immunol., December 1, 1999; 163(11): 6251 - 6260.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]

Home page
 J. Immunol.Home page
S. S. Tinkle, L. A. Kittle, and L. S. Newman
Partial IL-10 Inhibition of the Cell-Mediated Immune Response in Chronic Beryllium Disease
J. Immunol., September 1, 1999; 163(5): 2747 - 2753.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
L. L. Reznikov, A. J. Puren, G. Fantuzzi, G. R. Hamner, U. S. Schwertschlag, J. L. Ryan, and C. A. Dinarello
Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11
Innate Immunity, August 1, 1999; 5(4): 197 - 204.
[Abstract] [PDF]

Home page
 Int ImmunolHome page
M. Adib-Conquy, A.-F. Petit, C. Marie, C. Fitting, and J.-M. Cavaillon
Paradoxical priming effects of IL-10 on cytokine production
Int. Immunol., May 1, 1999; 11(5): 689 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
C. Jorgensen, F. Apparailly, and J. Sany
Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
Ann Rheum Dis, March 1, 1999; 58(3): 136 - 141.
[Full Text]

Home page
 J. Physiol.Home page
K. Ostrowski, T. Rohde, S. Asp, P. Schjerling, and B. K. Pedersen
Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans
J. Physiol., February 15, 1999; 515(1): 287 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
J.-M. Cavaillon, M. Adib-Conquy, C. Marie, and C. Fitting
Hyporesponsiveness in leukocytes in sepsis: in vitro models reveal paradoxical effects of IL-10
Innate Immunity, February 1, 1999; 5(1-2): 81 - 85.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
K. Asadullah, W.-D. Docke, M. Ebeling, M. Friedrich, G. Belbe, H. Audring, H.-D. Volk, and W. Sterry
Interleukin 10 Treatment of Psoriasis: Clinical Results of a Phase 2 Trial
Arch Dermatol, February 1, 1999; 135(2): 187 - 192.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. P. Wheeler and G. R. Bernard
Treating Patients with Severe Sepsis
N. Engl. J. Med., January 21, 1999; 340(3): 207 - 214.
[Full Text] [PDF]

Home page
 Toxicol PatholHome page
M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick
The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men"
Toxicol Pathol, January 1, 1999; 27(1): 123 - 133.
[Abstract] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Apparailly, C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgensen
Adenovirus-Mediated Transfer of Viral IL-10 Gene Inhibits Murine Collagen-Induced Arthritis
J. Immunol., June 1, 1998; 160(11): 5213 - 5220.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Brunetti, A. Colasante, N. Mascetra, M. Piantelli, P. Musiani, and F. B. Aiello
IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 915 - 919.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
H. Groux, M. Bigler, J. E. de Vries, and M.-G. Roncarolo
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
J. Immunol., April 1, 1998; 160(7): 3188 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
A Sablotzki, M Dehne, I Welters, T Menges, N Lehmann, G Gorlach, C Osmer, and G Hempelmann
Alterations of the cytokine network in patients undergoing cardiopulmonary bypass
Perfusion, December 1, 1997; 12(6): 393 - 403.
[Abstract] [PDF]

Home page
 Arch SurgHome page
L. M. Napolitano, M. M. Buzdon, H.-J. Shi, and B. L. Bass
Intestinal Epithelial Cell Regulation of Macrophage and Lymphocyte Interleukin 10 Expression
Arch Surg, December 1, 1997; 132(12): 1271 - 1276.
[Abstract] [PDF]

Home page
 BloodHome page
H. L. Dickensheets, S. L. Freeman, M. F. Smith Jr, and R. P. Donnelly
Interleukin-10 Upregulates Tumor Necrosis Factor Receptor Type-II (p75) Gene Expression in Endotoxin-Stimulated Human Monocytes
Blood, November 15, 1997; 90(10): 4162 - 4171.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Pajkrt, T. van der Poll, M. Levi, D. L. Cutler, M. B. Affrime, A. van den Ende, J. Wouter ten Cate, and S. J.H. van Deventer
Interleukin-10 Inhibits Activation of Coagulation and Fibrinolysis During Human Endotoxemia
Blood, April 15, 1997; 89(8): 2701 - 2705.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.